Ask AI
ProCE Banner Activity

Expert Perspectives on Frontline Therapy for Advanced Hodgkin Lymphoma

Clinical Thought

Learn how experts navigate real-world challenges—such as fertility preservation, autoimmune conditions, and patient fitness—to optimize patient outcomes across general, older, and pediatric populations of patients with Hodgkin lymphoma.

Released: July 29, 2025

Expiration: January 28, 2026

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Faculty Disclosure

Primary Author

Jonathan W. Friedberg, MD, has no relevant financial relationships to disclose.

Alex F. Herrera, MD: researcher: AstraZeneca, Bristol Myers Squibb, Genentech, Merck, Seagen; consultant/advisor/speaker: AbbVie, ADC, Allogene, AstraZeneca, Bristol Myers Squibb, Genentech, Genmab, Merck, Pfizer, Seagen, Takeda.

Kara M. Kelly, MD: consultant/advisor/speaker: Bristol Myers Squibb; researcher: Bristol Myers Squibb, Merck, Pfizer.